These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17303040)
1. Adverse cutaneous reactions to antimicrobials in patients with human immunodeficiency virus infection. Miller DD; Warshaw EM Dermatitis; 2007 Mar; 18(1):8-25. PubMed ID: 17303040 [TBL] [Abstract][Full Text] [Related]
2. Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection. Heller HM Clin Dermatol; 2000; 18(4):485-9. PubMed ID: 11024316 [No Abstract] [Full Text] [Related]
6. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Fiszenson-Albala F; Auzerie V; Mahe E; Farinotti R; Durand-Stocco C; Crickx B; Descamps V Br J Dermatol; 2003 Nov; 149(5):1018-22. PubMed ID: 14632808 [TBL] [Abstract][Full Text] [Related]
7. Adverse cutaneous drug reactions in AIDS. De Raeve L; Song M; Van Maldergem L Br J Dermatol; 1988 Oct; 119(4):521-3. PubMed ID: 2973344 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic perspectives on sulfonamide-induced cutaneous drug reactions. Reilly TP; Ju C Curr Opin Allergy Clin Immunol; 2002 Aug; 2(4):307-15. PubMed ID: 12130945 [TBL] [Abstract][Full Text] [Related]
9. Treatment can be continued for mild cutaneous reactions associated with efavirenz. Isaacs T; Ngwanya RM; Dlamini S; Peter J; Lehloenya R J Allergy Clin Immunol Pract; 2019; 7(5):1676-1678. PubMed ID: 30529062 [No Abstract] [Full Text] [Related]
10. [Cutaneous drug reactions in HIV-infected patients in the HAART era]. Blanes M; Belinchón I; Portilla J Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? Koopmans PP; van der Ven AJ; Vree TB; van der Meer JW AIDS; 1995 Mar; 9(3):217-22. PubMed ID: 7755908 [No Abstract] [Full Text] [Related]
12. Acute generalized exanthematous pustulosis: a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor. Aquilina C; Viraben R; Roueire A Arch Intern Med; 1998 Oct; 158(19):2160-1. PubMed ID: 9801185 [TBL] [Abstract][Full Text] [Related]
16. The changing spectrum of the cutaneous manifestation of HIV disease. Colebunders R; Vandenbruaene M Arch Dermatol; 1999 Apr; 135(4):471. PubMed ID: 10206061 [No Abstract] [Full Text] [Related]
18. Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization. Kardaun SH; de Waard MM; de Monchy JG Contact Dermatitis; 2009 Jul; 61(1):50-1. PubMed ID: 19659967 [No Abstract] [Full Text] [Related]
19. Cutaneous drug reactions in human immunodeficiency virus infection. Coopman SA; Stern RS Arch Dermatol; 1991 May; 127(5):714-7. PubMed ID: 1827244 [No Abstract] [Full Text] [Related]
20. Recognition and management of severe cutaneous drug reactions. Knowles SR; Shear NH Dermatol Clin; 2007 Apr; 25(2):245-53, viii. PubMed ID: 17430761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]